#ASCO25: Jazz outlines full survival data for lung cancer drug Zepzelca
A drug from Jazz Pharmaceuticals that has yet to read out confirmatory data in lung cancer succeeded in another Phase 3 trial, as the company is slated to present overall survival data at the American ...
A drug from Jazz Pharmaceuticals that has yet to read out confirmatory data in lung cancer succeeded in another Phase 3 trial, as the company is slated to present overall survival data at the American ...
